| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90670 |
|
2,153 |
1,240 |
$339K |
| 90686 |
|
14,481 |
13,415 |
$286K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,423 |
5,446 |
$127K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,999 |
7,445 |
$77K |
| 0001A |
|
4,517 |
4,227 |
$73K |
| 0002A |
|
4,431 |
4,156 |
$73K |
| 90732 |
|
476 |
307 |
$40K |
| 90674 |
|
2,750 |
2,621 |
$39K |
| 90750 |
|
283 |
265 |
$23K |
| 0012A |
|
1,384 |
1,349 |
$23K |
| 0011A |
|
1,191 |
1,157 |
$22K |
| 91320 |
|
385 |
310 |
$10K |
| 0004A |
|
507 |
497 |
$8K |
| 0064A |
|
541 |
524 |
$6K |
| G0008 |
Administration of influenza virus vaccine |
10,191 |
9,228 |
$5K |
| 0054A |
|
454 |
431 |
$4K |
| 90715 |
|
145 |
142 |
$4K |
| 90662 |
|
287 |
283 |
$4K |
| 0003A |
|
227 |
220 |
$3K |
| 0071A |
|
241 |
238 |
$3K |
| 91322 |
|
140 |
102 |
$3K |
| 0124A |
|
571 |
493 |
$2K |
| 0051A |
|
204 |
185 |
$2K |
| 0072A |
|
188 |
182 |
$1K |
| 90756 |
|
74 |
74 |
$1K |
| 0052A |
|
185 |
172 |
$886.99 |
| 90656 |
|
183 |
179 |
$860.48 |
| 90653 |
|
48 |
48 |
$784.00 |
| 0031A |
|
58 |
51 |
$771.54 |
| 0134A |
|
311 |
245 |
$724.44 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
252 |
178 |
$708.42 |
| 0053A |
|
74 |
69 |
$560.00 |
| 90658 |
|
27 |
27 |
$480.00 |
| 90694 |
|
34 |
33 |
$440.00 |
| 0013A |
|
24 |
24 |
$320.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
30 |
28 |
$10.20 |
| G0009 |
Administration of pneumococcal vaccine |
2,551 |
1,464 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
63 |
55 |
$0.00 |
| 0154A |
|
13 |
12 |
$0.00 |
| 90734 |
|
15 |
12 |
$0.00 |